CMAC 2002; 4(1) | CMAC

CMAC 2002; 4(1)

According to the guidelines of the Infectious Diseases Society of America, 2000.
Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(1):4-14
PDF

During prospective study carried out in 1998–2000 risk factors, spectrum of pathogens, treatment options and mortality in 45 episodes …
Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(1):15-21
PDF

Diarrhea, which is associated with the usage of antimicrobials, is one of the important problems in clinical practice. This article …
Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(1):22-32
PDF

The rates of nasopharyngeal carriage of Haemophilus influenzae and epidemiology of its antimicrobial resistance in healthy children …
Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(1):33-41
PDF

Medical equipments, instruments and hands of medical personnel serve as one of the most important vehicles for the transmission of …
Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(1):42-48
PDF

The objective of this study was to estimate the potential economic and clinical effects of treatment of chronic hepatitis B with …
Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(1):49-60
PDF

Streptococcus pneumoniae is one of the leading pathogens causing meningitis, otitis media, sinusitis, and community-acquired pneumonia …
Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(1):61-69
PDF

Acute rhinosinusitis is one of the most common disorders in otolaryngology and is on 5th place among all diseases based on the amount …
Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(1):70-82
PDF